From 1 October 2021 all nicotine vaping products, such as nicotine e-cigarettes, nicotine pods and liquid nicotine, will be Schedule 4 (prescription only) medicines.
Consumers will require a prescription for all purchases of nicotine vaping products. This includes products purchased both in Australia and from overseas. Further information about the reasons for this change is available on the Nicotine vaping product access page.
Nicotine replacement therapies (NRTs) (including sprays, patches, lozenges, chews and gums) that do not require a prescription will continue to be available from pharmacies and some retail outlets. There are no changes to the availability of vaping products (including e-cigarettes) and vaping devices that do not contain nicotine.
Visit the TGA website and the NPS website for all relevant information; and refer to this downloadable infographic if you are interested in becoming an authorised prescriber.
Consumers will require a prescription for all purchases of nicotine vaping products. This includes products purchased both in Australia and from overseas. Further information about the reasons for this change is available on the Nicotine vaping product access page.
Nicotine replacement therapies (NRTs) (including sprays, patches, lozenges, chews and gums) that do not require a prescription will continue to be available from pharmacies and some retail outlets. There are no changes to the availability of vaping products (including e-cigarettes) and vaping devices that do not contain nicotine.
Visit the TGA website and the NPS website for all relevant information; and refer to this downloadable infographic if you are interested in becoming an authorised prescriber.